GSK’s RSV vaccine first to get EU regulator’s nod, ET HealthWorld
Add To Favorites New Delhi: The European Medicines Agency (EMA) on Wednesday recommended authorization of GSK’s Arexvy vaccine for respiratory syncytial virus (RSV) in adults aged 60 and older, putting Europe on track to approve the world’s first such vaccine. The recommendation puts GSK ahead of rival Pfizer Inc in the race to tap into …
GSK’s RSV vaccine first to get EU regulator’s nod, ET HealthWorld Read More »
